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Ovarian ﬁbroma is the commonest benign tumor of the ovarian stroma. The cellular subtype accounts for around 10% of ovarian
ﬁbromatous tumors. The cellular ﬁbroma is a tumor of uncertain malignant potential that may recur or be associated with
peritoneal implants. Usually these are solid tumors, sometimes with small areas of cystic degeneration. This case is reported to
highlight an unusual feature for an ovarian ﬁbroma: the tumor was predominantly cystic with a small solid part; the multiple
cavities contents consisted of viscous liquid that solidiﬁed under room temperature. The multiloculated cysts, the mucinous
contents, and the solid areas simulated a borderline mucinous ovarian tumor on both CT scan and gross pathologic examination.
1.Introduction
Ovarianﬁbromaisthecommonestbenigntumoroftheovar-
ian stroma (4% of all ovarian neoplasms), and it can occur at
anyage[1].Thecellularsubtype,approximately10%ofovar-
ian ﬁbromatous tumors, exhibit hypercellularity, increased
mitotic activity, and mild-to-moderate nuclear atypia [2].
The cellular ﬁbroma is a tumor of uncertain malignant
potential that may recur or be associated with peritoneal
implants. The degree of mitotic activity is the main parame-
ter for diﬀerentiatingcellularﬁbromafromﬁbrosarcoma[2].
Fibrosarcomas usually exhibit moderate-to-severe nuclear
atypia and mitotic counts of 4 or more per 10 high-
power ﬁelds (HPFs). Macroscopically, the cellular ﬁbroma
has a whitish appearance resembling uterine leiomyoma,
a generally solid consistency and, sometimes, small areas
of cystic degeneration and stromal edema. Clinically, it is
asymptomatic and may typically be detected during routine
gynecological examinations. Its behavior is usually benign,
but the completeness of excision and presence or absence
capsule rupture are important prognostic parameters [3].
2.ClinicCase
A 53-year-old woman (G4N4A0) suﬀered right-side abdom-
inal pain for eight months, associated with abdominal
distension, increased abdominal size, nausea and vomiting.
Ultrasonography (6 months before surgery): cystic image
with smooth surfaced wall and coarse septa in the center;
hypovascularization to Doppler study, measuring 19.9 ×
12.9 × 19.2cm; volume: 2562cm3; located in the middle
region, occupying the upper and lower abdomen. Computed
tomography (CT)—5 months before surgery: a complex
large-volume lesion extending from the pelvis to the upper
abdomen (20×20×15cm; volume: 3000mL), without signs
of ureteral compression, ascites or enlarged lymph nodes2 Case Reports in Medicine
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Figure 1: (a) Not contrasted helical computed tomography (CT) of the abdomen; large cyst (water ROI mean 0–20HU; this cyst 13.12HU)
with well deﬁned limits and ﬁnely heterogeneous appearance; (b) Contrast enhanced helical CT of the abdomen; arrow indicates a contrast
enhanced solid area in the cyst wall, suggesting malignancy; (c) Partially opened surgical specimen showing the multiloculated cystic
appearance, with mucinous content and thin wall; (d) Solid, whitish, and elastic area seen at depth, which corresponded microscopically to
the regions with more cellularity.
(Figures 1(a) and 1(b)). Tumor markers CA 125, CA 15.3,
CA 19.9, CEA, α-fetoprotein, and β-HCG were negative.
Exploratory laparotomy revealed a right-side adnexal cystic
and a moderate quantity of ascitic ﬂuid. The uterine annexal
cystic tumor was sent to Department of Pathology to be
analyzed by frozen biopsy. The lesion was considered consis-
tent with cystic tumor of borderline malignancy, mucinous
probably, or association between two tumors. The patient
then underwent expanded total abdominal hysterectomy.
The ascitic ﬂuid, right and left parietocolic gutter, right
and left pelvic lymph nodes, infracolic omentum, hepatic
capsule, uterus, and contralateral ovary were free from
neoplasia.
3.Pathologic Study
Gross pathologic ﬁndings: the ovarian tumor measured
27 × 27 × 15cm and weighed 6630g, with smooth grayish
external surface and absence of macroscopic rupture. Upon
opening the cystic tumor, a multiloculated appearance with
cavities was observed (Figure 1(c)). The tumor was covered
with a thin wall of 0.1cm in thickness that was generally
smooth except in one area measuring 5 × 3 × 2cm, that
was solid, whitish and with ﬁbroelastic feature (Figure 1(d)).
The cavities were ﬁlled with a clear viscous ﬂuid when
fresh, but it gradually turned gelatinous material under
room temperature, suggesting mucinous tumor. Epithelium
was not seen lining the cysts in the frozen sections biopsy.
However, the macroscopic features of multiloculated cysts,
mucinouscontents,andthesolidarea,whichwasmicroscop-
ically hypercellular with mild atypia, led to the diagnosis of
cystic tumor of borderline malignancy, mucinous, probably
o ra s s o c i a t i o nb e t w e e nt w ot u m o r so nf r o z e nb i o p s y .T h e
remaining material was then ﬁxed in buﬀered formalin and
processed for paraﬃn, submitted after the microtome, and
stained by Hematoxylin-eosin (HE) and immunohistochem-
ical; 30 blocks were made of the neoplasm by sampling,
extensively, the solid and cystic areas.
Microscopically, the tumor showed alternating solid
and cystic areas. However, there was no epithelium lining
the cavities at any location; the cavities were limited by
granulation tissue that, in turn, was surrounded by myxoid
alteration. Part of the solid areas were slightly hypercellular
with nonatypical spindle cells arranged in storiform pattern,
compatible with ﬁbroma (Figure 2(a)). Frequently small
foci were observed with incipient cystic degeneration. The
macroscopically largest solid area was moderately to highly
cellular with slight nuclear atypia and scant mitotic ﬁgures.Case Reports in Medicine 3
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Figure 2: (a) Photomicrograph of the wall of the cystic area (asterisk inside the larger cavity) showing no epithelium lining and other
similar, smaller cavities, with ﬁbroma in the middle, with usual cell density (HE—100x); (b, c) and (d) Representation of the solid area
compatible with cellular ﬁbroma, noting evident high cell density ((b) HE-100x), mild atypia ((c) HE—400x) and mitosis (arrow); (d)
MIB-1 immunostaining (400x) showing sparse positive cells (2-3%).
Mitotic ﬁgures were counted in 100HPF, divided into 10
sets of 10 ﬁelds; no more than 3 mitoses/10HPF were seen
(Figures 2(b) and 2(c)). Immunohistochemical analysis was
performed using the polymer technique with the following
sera: anti-cytokeratin (clone AE1/AE3, Dako, 1:400), anti-
EMA (clone E29, Dako 1:200), CD34 (clone QBEnd/10;
Novocastra, 1:600), anti-vimentin (clone VIM3B4, Dako
1:1200),antismoothmuscleactin(clone1A4,Dako,1:200),
anti-desmin (clone D33, Dako, 1:100), and anti-ki67
(clone MIB-1, Dako, 1:500). Immunohistochemical analysis
revealed that the tumor was negative for AE1AE3, EMA,
CD34 and desmin, while focally positive for vimentin and
actin 1A4. MIB-1 (Figure 2(d)) was positive in 2-3% tumor
cells(basedon1000tumourcellscount).Weconcluded,after
its inclusion in paraﬃn, that it was a cellular ﬁbroma.
After surgery patient progressed well and is currently
living in good health and without signs of tumor recurrence
(follow up: 33 months).
4. Discussion
This case is interesting in several respects. The patient’s
complaints were gastrointestinal disorders, characterized by
colic pain, bloating, nausea, and vomiting that started and
had been progressing for about 8 months. The ﬁrst place she
sought medical care was at the clinic of digestive diseases.
After voluminous abdominal mass was detected by imaging
studies, she was referred for gynecologic evaluation. This
fact is not new in relation to ovarian neoplasms. Early
ovarian cancer-associated symptoms constitute a constella-
tion of mostly nongynecological complaints, suggesting a
visceral disturbance, which do not point immediately to a
pelvic origin. Abdominal bloating and pain predominate
with recent onset and multiple symptomatic episodes [4].
Gastrointestinal and urinary symptoms and fatigue/malaise
may be part of the symptom complex. These symptoms
are caused by compression of the stomach and intestine by
increased adnexal. In the study of Irving et al. [3], the mean
age of 35 patients with benign cellular ﬁbroma was 51 years,
roughly the same age as our patient.
Although the patient had ascites, commonly found in
women with ovarian ﬁbroma, both serum CA 125 and chest
X-ray did not show the presence of pleural eﬀusion. These
ﬁndings departed the diagnosis of Meigs’ syndrome. “This
syndrome may be suspected when faced with an important
pleural eﬀusion, a very elevated CA-125 serum level, a
negative cytologic examination of the ascitic eﬀusion and no
peritoneal implant on CT-scan” [5].4 Case Reports in Medicine
The surgical time was based on the diagnosis of cystic
tumor of borderline malignancy by frozen biopsy, patient’s
age, CT, and intraoperative ﬁndings which showed ascites.
Cellular ﬁbromas are predominantly solid. Cystic areas
are usually small and without multiloculation. But “some
ﬁbromas undergo proeminent cystic degeneration and may
be misconstrued as surface epithelial stromal tumours.
However, the cyst (pseudocyst) do not have an epithelial
lining. ”[6]. We found no reports of cellular ﬁbroma with
multicystic mucinous content. We found one report of
cellular ﬁbroma entirely multicystic with no solid areas but
the authors do not relate the contents [3], and another
case predominantly cystic [2], however the authors did not
describe whether the tumor was multicystic or not and the
content type. In this present case there was a predominance
ofcysticcomponent;duetosolid/cysticfeaturewithmultiple
cysts containing mucinous material, the tumor simulated
a borderline mucinous ovarian tumor on both CT and
gross pathological examination. The patient was treated
on the basis of this diagnosis; but considering that the
ﬁnal diagnosis was a cellular ﬁbroma, the ovary could
have been the only structure removed. However, cellular
ﬁbroma is a tumor of uncertain malignant potential. It is
capable of locally aggressive growth if incompletely excised
[2]. Moreover, metastasis occasionally occurs, indicating
that criteria for diﬀerentiating between cellular ﬁbroma and
ﬁbrossarcoma are imperfect. In the study of Prat and Scully,
the microscopic feature that correlated best with prognostic
was the amount of mitotic activity, with the degree of
nuclear atypia less helpful [2]. In this series, 4 of 11 cases
of cellular ﬁbroma with atypia degree 2 in 3 did not have
any complication or recurrence. They also emphasize that
“completeness of removal of the tumor has been considered
in determining the prognosis as well as mitotic count”
[2].
Irving et al. [3] studied 75 cases of cellular ﬁbromas of
the ovary and suggested the term “mitotic active cellular
ﬁbroma (MACF)” to cellular ﬁbromatous neoplasm with
bland cytology with ≥4 mitosis/10HPF. They pointed out
thatthetermﬁbrosarcomashouldbereservedforﬁbroblastic
tumour with moderate or severe atypia and high mitotic
rate. They still suggested that aggressiveness could occur in
cellular ﬁbromas with adhesions at the time of resection
or tumor rupture during surgery [3]. In the present case,
there were no adhesions or rupture of the tumor. The
patient is alive 33 months after surgery, without recurrence
ormetastases.Thetumorwaswidelysampledformicroscopy
(30 blocks), considering its unusual feature. No epithelium
was found lining the cavities. There were several areas
of cystic degeneration, where the tumor was less cellular.
In hypercellular areas mild atypia and scattered mitoses
were found having diﬀerential diagnosis with ﬁbrosarcoma.
Nevertheless, ﬁbrosarcoma usually exhibit a combination
of moderate-to-severe atypia, high mitotic rate and an
aggressive clinical course [3]. But recently a case of well-
diﬀerentiated ovarian ﬁbrosarcoma has been described,
with low-grade cytological atypia and 1-2 mitosis/10HPF
developing liver metastasis one year later [7]. Those authors
suggested that in addition to the macroscopic aspect, high
rates for Ki-67 (MIB-1) could contribute to the diagnosis of
malignancy, despite having a low visual mitotic rate.
Other authors also considered MIB-1 to be a useful
additional parameter for distinguishing between ovarian
cellular ﬁbroma and ﬁbrosarcoma [8]. Huang et al. [9], in
a retrospective study, also concluded that mitotic activity,
and MIB-1-positive cells were identiﬁed as important factors
in the diagnosis of ovarian ﬁbrosarcoma. Usually, cellular
ﬁbromas showed less than 3% of MIB-1-positive cells. Delay
in ﬁxation changes mitotic rate; “decrease in counts is
largely due to their reduced identiﬁability and only partly
attributable to a completion of the cell cycle.” However,
the ﬂow cytometric data did not change substantially [10].
Perhaps a reduction of identiﬁable mitoses occurred in a
recently reported case [7], due to extensive ischemic changes,
while the positivity rate for MIB-1 that was surprisingly
high (60%). However, in the case described here, both the
rate of mitosis (maximum 3 mitoses/10HPF) and MIB-1 (2-
3%), as well as alternating areas of low and high cellularity,
no adherence or rupture and no aggressive clinical course
ﬁndings are consistent with a cellular ﬁbroma diagnosis.
In conclusion, ovarian cellular ﬁbromas are usually
solid and when cysts are present they are often scant and
small. In the present case, the multiloculated cysts, the
mucinouscontentsandthesolidareassimulatedaborderline
mucinous ovarian tumor on both CT and gross pathological
examination.
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